Xenetic Biosciences, Inc.
XBIO
$2.30
-$0.08-3.36%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 5.63% | -15.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.63% | -15.45% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 5.63% | -15.45% | |||
| SG&A Expenses | -5.36% | -34.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 56.95% | -46.04% | |||
| Operating Income | -120.04% | 62.65% | |||
| Income Before Tax | -141.47% | 65.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -141.47% | 65.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -141.47% | 65.72% | |||
| EBIT | -120.04% | 62.65% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -141.45% | 65.75% | |||
| Normalized Basic EPS | -141.47% | 65.75% | |||
| EPS Diluted | -141.45% | 65.88% | |||
| Normalized Diluted EPS | -141.47% | 65.75% | |||
| Average Basic Shares Outstanding | 0.03% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
